Spatial PD-L1, immune-cell microenvironment, and genomic copy-number alteration patterns and drivers of invasive-disease transition in prospective oral precancer cohort.
Saved in:
| Title: | Spatial PD-L1, immune-cell microenvironment, and genomic copy-number alteration patterns and drivers of invasive-disease transition in prospective oral precancer cohort. |
|---|---|
| Authors: | William WN Jr; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Hospital BP, a Beneficência Portuguesa de São Paulo, São Paulo, Brazil., Zhang J; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Zhao X; Department of Biochemistry and Molecular Pharmacology, Institute for Systems Genetics, New York University Langone Health, New York, New York, USA., Parra ER; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Uraoka N; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lin HY; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Peng SA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., El-Naggar AK; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Rodriguez-Canales J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Song J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gillenwater AM; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Myers JN; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gold KA; Moores Cancer Center, University of California San Diego, La Jolla, California, USA., Ferrarotto R; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hwu P; Moffitt Cancer Center, Tampa, Florida, USA., Davoli T; Department of Biochemistry and Molecular Pharmacology, Institute for Systems Genetics, New York University Langone Health, New York, New York, USA., Lee JJ; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Heymach JV; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Papadimitrakopoulou VA; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Pfizer Inc, New York, New York, USA., Lippman SM; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Moores Cancer Center, University of California San Diego, La Jolla, California, USA. |
| Source: | Cancer [Cancer] 2023 Mar 01; Vol. 129 (5), pp. 714-727. Date of Electronic Publication: 2023 Jan 03. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1097-0142 |
|---|---|
| DOI: | 10.1002/cncr.34607 |
